Health
FDA approves controversial new drug designed to slow the progression of ALS
The Food and Drug Administration on Thursday approved a controversial new drug designed to slow the progress of Lou Gehrig’s disease, a victory for patients and advocates despite limited evidence that the drug is effective. The drug, from the Massachusetts-based Amylyx Pharmaceuticals, joins only a handful of drugs approved by the agency for the fatal neurodegenerative disease […]
Read More
Here’s why Biogen’s promising Alzheimer’s drug data is also good news for Eli Lilly
We don’t own Eli Lilly exclusively for its potential Alzheimer’s treatment. However, we still find Biogen’s topline data to be very encouraging for Lilly. Source
Read More
A single dose of monkeypox vaccine provides some protection against infection, CDC says
Los Angeles, CA – August 10: Luis Garcia, a registered nurse, prepares Monkeypox virus vaccine at St.John’s Well Child & Family Center on Wednesday, Aug. 10, 2022 in Los Angeles, CA. Irfan Khan | Los Angeles Times | Getty Images People at risk for monkeypox who have not received a single dose of vaccine are […]
Read More
2 takeaways from our daily meeting: What’s behind the bounce and Club stocks in the news
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Market gets an oversold bounce Quick Club mentions: AAPL, LLY, EL 1. Market gets an oversold bounce U.S. stocks recovered after falling earlier Wednesday. Treasury yields pulled back from their highs and […]
Read More
Covid vaccination linked to slight increase in menstrual cycle, NIH study confirms
A healthcare worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, U.S., on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images Covid-19 vaccination is linked to a slight increase in the length of a women’s menstrual cycle, delaying the beginning […]
Read More
Texas AG Ken Paxton fled home with his wife to avoid subpoena in abortion case, court filing says
Texas Attorney General Ken Paxton fled his home to avoid being served a subpoena Monday in a federal lawsuit filed by groups seeking to help Texans receive out-of-state abortions, court filings show. Paxton ran from the garage of his home in McKinney, Texas, into a truck driven by his wife, State Sen. Angela Paxton, while […]
Read More
Biogen to pay $900 million to settle allegations it paid doctors kickbacks to prescribe multiple sclerosis drugs
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen will pay $900 million to settle a lawsuit that alleged the company gave doctors kickbacks to encourage them prescribe its drugs, the Justice Department announced on Monday. A former Biogen employee turned whistleblower, Michael Bawduniak, sued the pharmaceutical company in 2012 on behalf of […]
Read More
Pfizer asks FDA to authorize omicron Covid booster shots for kids ages 5 to 11
Jack Wasserman, 6, receives a Pfizer-BioNTech coronavirus disease (COVID-19) booster vaccine in Schwenksville, Pennsylvania, U.S., May 19, 2022. Hannah Beier | Reuters Pfizer on Monday asked the Food and Drug Administration to authorize its new Covid booster shots that target the omicron BA.5 subvariant for children ages 5 to 11. Pfizer’s application to the FDA […]
Read More
Moderna asks FDA to authorize omicron Covid boosters for children as young as 6 years old
Following CDC approval for vaccination of children aged 6 months to 5 years, 4 year-old Eleanor Kahn sits with her father Alex, as nurse Jillian Mercer administers the Moderna vaccine for the coronavirus disease (COVID-19) at Rady Children’s Hospital in San Diego, California, U.S., June 21, 2022. Mike Blake | Reuters Moderna has asked the […]
Read More
2 takeaways from Thursday’s ‘Morning Meeting’: We want to buy on market weakness
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. We have no choice but to buy Quick mentions: MRVL, LLY, NVDA, META 1. We have no choice but to buy Stocks slumped on Thursday, continuing their losing streak after […]
Read More